A divided Supreme Court on Thursday indefinitely extended a freeze on strict new restrictions for dispensing the widely used abortion pill mifepristone while an underlying legal fight over the drug plays out. Why it matters: The widely expected order provides legal certainty for pharmacies, telehealth companies and clinicians caught up in the latest battle over accessing the pill. - Justices Samuel Alito and Clarence Thomas dissented. - Teleprescribing and mailing of abortion drugs now account for more than 60% of all abortions in the health system. Driving the news: Alito had issued two earlier stays freezing a ruling by the 5th U.S. Circuit Court of Appeals that would have required patients to see a provider in person before getting…
The CEO of the main pharmaceutical company trade group on Wednesday called for the next Food and Drug Administration commissioner to "calm the waters" and ensure stability as drug companies develop new treatments. Why it matters: The FDA has faced a tumultous several months leading up to Commissioner Marty Makary's resignation Tuesday, with staff layoffs and top leaders heading out the door. What they're saying: "What we really need from the next leader of the FDA is to calm the waters and reestablish that certainty and predictability," PhRMA CEO Steve Ubl said at Axios' Future of Health Summit. - Bristol Myers Squibb CEO Chris Boerner sounded a similar theme, pointing to the years of work that go into developing a drug. - "What we need…
On Wednesday, May 13 at 2:10pm ET, Axios Live will host our second annual Future of Health Summit convening conversations unpacking how our changing landscape is redefining the high-stakes world of health care. Featured speakers include Cynthia Bailey, model and Bravo personality; Caryn Seidman Becker, chairman and CEO of CLEAR; Chris Boerner, board chair and CEO of Bristol Myers Squibb and board chair-elect of PhRMA; Emily Capodilupo, senior vice president of data science and research at WHOOP; Felicia DellaFortuna, chief financial officer of Weight Watchers; Tom Engels, administrator of the Health Resources and Services Administration; David Goldhill, co-founder and CEO of Sesame; Johanna Hellrigl, chef and owner of Ama and board member…
Steve Ubl built PhRMA into a more aggressive operation as its longtime leader. The White House has tangled with Ubl and the pharmaceutical industry in its bid to lower drug prices.
PULSE POINTSWHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs.WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance […] The post More Pharma Firms Want to Make Drug Price Deals With Trump. appeared first on The National Pulse .
PULSE POINTS WHAT HAPPENED: Some pharmaceutical companies not directly contacted by the Trump administration to lower U.S. drug prices are seeking to craft their own agreements to avoid potential tariffs and price-setting programs. WHO WAS INVOLVED: The Trump administration, pharmaceutical companies including Bayer, Pfizer, Eli Lilly, and industry groups such as PhRMA and the Midsized Biotech Alliance of America. WHEN & WHERE: Ongoing discussions following directives issued by the Trump administration in the U.S.; recent comments made at the JP Morgan Healthcare Conference in San Francisco. KEY QUOTE: “The Trump administration, of course, wants to negotiate deals that meaningfully lower drug prices for American patients with every…Open